Emerging cell-based and cell-free therapeutic strategies for vitiligo

Area of Science:

• Dermatology and Regenerative Medicine

Background:

• Vitiligo is a chronic skin condition causing pigment loss due to melanocyte dysfunction.
• Current treatments like corticosteroids and phototherapy have limited efficacy.
• Emerging therapies offer new hope for vitiligo management.

Purpose of the Study:

• To review novel therapeutic strategies for vitiligo.
• To explore mechanisms, efficacy, and challenges of new treatments.
• To compare cell-based and cell-free approaches for vitiligo.

Main Methods:

• Review of current literature on vitiligo treatments.
• Analysis of cell-based therapies (melanocyte transplantation, mesenchymal stem cells).
• Analysis of cell-free therapies (platelet-rich plasma, stem cell secretome, exosomes).

Main Results:

• Melanocyte transplantation shows high success in stable vitiligo.
• Mesenchymal stem cells (MSCs), PRP, stem cell secretome, and exosomes are promising alternatives.
• These novel therapies target melanocyte replenishment, immune modulation, and oxidative stress reduction.

Conclusions:

• Novel cell-based and cell-free therapies offer potential for vitiligo treatment.
• Stem cell and exosome-based therapies show significant promise for personalized, long-term vitiligo management.
• Further research is needed to overcome translational challenges for widespread clinical application.